Results 41 to 50 of about 21,592 (229)

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study [PDF]

open access: yesPatient Safety and Quality Improvement Journal, 2016
Introduction: Osteoporosis is a common problem in postmenopausal women. Numerous studies investigated the effects of vitamin K on bone health, which yielded conflicting results.
Mohammad Hassan Jokar   +3 more
doaj  

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

open access: yes, 2010
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In ­randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell   +4 more
core   +1 more source

Upconversion nanoparticles coated with Alendronate and PEG-conjugated Alendronate [PDF]

open access: yes, 2018
Upconverting nanoparticles (UCNPs) have gained traction as diagnostic and imaging probes for biological applications due to their many unique optical properties.
Najib, Hifza
core   +1 more source

Bacterial DnaK Promotes CHIP‐Mediated GPX4 Degradation: A Bone‐Targeted DNAzyme–Nanozyme Strategy for Repair of Infected Bone Defects

open access: yesAdvanced Science, EarlyView.
Staphylococcus aureus DnaK promotes ubiquitination and degradation of glutathione peroxidase 4 (GPX4) through the C terminus of Hsc70‐interacting protein (CHIP) in bone marrow mesenchymal stem cells, inducing ferroptosis‐associated injury and impairing osteogenesis.
Le Gao   +7 more
wiley   +1 more source

Biomimetic Nanomedicine for Aging‐Impaired Bone Regeneration: From Microenvironmental Dysfunction to Precision Therapeutics

open access: yesAdvanced NanoBiomed Research, EarlyView.
Aging disrupts the cellular, immune, vascular, and neural processes required for bone regeneration. This review connects these pathological barriers with biomimetic nanomedicine design, highlighting strategies for cellular rejuvenation, immune modulation, vascular regeneration, and neuro–bone coupling.
Zeyu Wang   +12 more
wiley   +1 more source

Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin‐3 down‐regulation

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2018
Background A global consensus on the loss of skeletal muscle mass and function in humans refers as sarcopenia and cachexia including diabetes, obesity, renal failure, and osteoporosis. Despite a current improvement of sarcopenia or cachexia with exercise
Hsien‐Chun Chiu   +5 more
doaj   +1 more source

A fast and simple spectrofluorometric method for the determination of alendronate sodium in pharmaceuticals [PDF]

open access: yesBioImpacts, 2014
Introduction: Alendronate sodium enhances bone formation and increases osteoblast proliferation and maturation and leads to the inhibition of osteoblast apoptosis.
Jafar Ezzati Nazhad Dolatabadi   +3 more
doaj   +1 more source

Multifunctional polycaprolactone‐based composite fibers with icariin and glutathione for effective repair of critical‐sized bone defects

open access: yesBMEMat, EarlyView.
A multifunctional PCL‐based scaffold co‐delivering Icariin and Glutathione synergistically enhances osteogenesis, angiogenesis, and oxidative stress resistance, achieving near‐complete repair of critical‐sized bone defects in vivo. This cell‐free platform represents a promising strategy for accelerated bone regeneration.
Abdurohman Mengesha Yessuf   +11 more
wiley   +1 more source

Rheological and Mechanical Assessment of Injectable Hydrogels: A Framework for Structure–Property Analysis

open access: yesPolymer Engineering &Science, EarlyView.
A rheological and mechanical assessment framework to construct structure‐property‐application relationships for injectable hydrogels. ABSTRACT Injectable hydrogels have attracted massive research attention thanks to their potential biomedical applications.
Hai Xin   +2 more
wiley   +1 more source

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

open access: yesBMC Musculoskeletal Disorders, 2010
Background A rise in gastrointestinal (GI) adverse events (AEs) and a decline in bone mineral density (BMD) was observed in patients previously tolerant to brand alendronate shortly after generic versions were introduced in July 2005 to the Canadian ...
Papaioannou Alexandra   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy